Because Expertise Matters
Join Cyberounds®, an online education community for health professionals Sign Up

Log In


Diagnosis and Treatment of Epithelial Ovarian Cancer

Ovarian cancer is the most lethal of all the gynecologic malignancies.
CME credit is no longer available for this conference.

Course Authors

Renata Urban, M.D., and Jonathan S. Berek, M.D., M.S.S.

Dr. Urban is a Resident and Dr. Berek is Professor and Chair, Department of Obstetrics and Gynecology, Stanford University Medical Center, Stanford, CA.

Within the past 12 months, Drs. Berek and Urban report no conflicts of interest or competing interests.

Albert Einstein College of Medicine, CCME staff and interMDnet staff have nothing to disclose.

Estimated course time: 1 hour(s).

Albert Einstein College of Medicine – Montefiore Medical Center designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

In support of improving patient care, this activity has been planned and implemented by Albert Einstein College of Medicine-Montefiore Medical Center and InterMDnet. Albert Einstein College of Medicine – Montefiore Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Learning Objectives

Upon completion of this Cyberounds®, you should be able to:

  • Discuss the symptoms and signs associated with ovarian cancer

  • Discuss the staging and surgical management of epithelial ovarian cancer

  • Discuss common medical treatments and complications in epithelial ovarian cancer.



The opinions expressed herein are those of the authors and do not necessarily represent the views of the sponsor or its publisher. Please review complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.


Please click below to accept the terms of this CME activity

Courses You Might Like

Sex-Related Differences in Addiction

While more men use and are addicted to drugs, women who become addicted progress faster through the landmark stages from initial use to dependence.
Authors: Jill B. Becker, Ph.D. and Jillian E. Hardee, Ph.D.
Estimated Time: 3 Hours

Caring for Women and Their Families: The Essential Role of Reproductive Rights

Medical professionals must manage reproductive rights in a highly politicized environment.
Authors: Nada L. Stotland, M.D., M.P.H.
Estimated Time: 1 Hour

Current and Emerging Therapies for Vulvo-vaginal Atrophy

Vulvo-vaginal atrophy in peri- and post-menopausal women is caused by declining, then deficient estrogen levels, and affects more than half of otherwise healthy women over age 60.
Authors: Nancy A. Phillips, M.D., and Gloria A. Bachmann, M.D.
Estimated Time: 1 Hour

Current Management of Endometriosis

Endometriosis remains one of the most complex pathologies faced by OBGYNs and primary care physicians.
Authors: Kenan Omurtag, M.D., and Amber R. Cooper, M.D., M.S.C.I.
Estimated Time: 1 Hour

Endometrial Cancer

Endometrial carcinoma is the most common female genital tract neoplasm in the United States.
Authors: Yevgeniya Ioffe, M.D., and Israel Zighelboim, M.D.
Estimated Time: 1 Hour

Evaluation and Treatment of Polycystic Ovary Syndrome

Androgen Excess (AE)-PCOS Society recommended that PCOS be defined by clinical/biochemical hyperandrogenism.
Authors: Daniel A. Dumesic, M.D., Mark O. Goodarzi, M.D., Ph.D., Gregory D. Chazenbalk, Ph.D., David Geller, M.D., and David H. Abbott, Ph.D.
Estimated Time: 1 Hour